The most recent Success stories from EU Research. Select a theme or country from the menus on the left to see more articles
Health & life sciences - Medical research
Tick (check) box to add article to PDF "basket"
Management and treatment of neurological diseases is one of the biggest challenges facing medicine today. EU-funded researchers are developing computational tools to improve understanding of how such diseases progress as a means to help treat patients.
Published: 22 June 2018
An EU-funded project aims to identify and maximise the potential of novel vaccines to end the global tuberculosis epidemic. These could save lives, stem the spread of infection and shorten treatment for the often deadly, airborne disease.
Published: 21 June 2018
An EU-funded project has established a data-collection and evaluation infrastructure to monitor iodine deficiency across Europe. The project's database and EU-wide monitoring system will feed into national efforts to ensure Europeans get enough iodine to stay healthy.
Published: 15 June 2018
A loan supported by the InnovFin-EU finance for innovators initiative under the EU's Horizon 2020 programme and extended by the European Investment Bank is helping France-based biotech company Valneva develop a Zika vaccine that is safe during pregnancy. This could protect unborn babies from birth defects linked to the mosquito-borne virus.
Published: 13 June 2018
Published: 12 June 2018
EU-funded researchers are seeking to improve the diagnosis and management of patients with fever through the identification of new biomarkers that can differentiate between bacterial and viral infection. Once found, the biomarkers will be evaluated across different European healthcare models.
Published: 6 June 2018
An EU-funded project is developing advanced three-dimensional computational and physical models of breast tumours, providing the medical community with powerful new instruments to tackle breast cancer. The initiative will reveal the possibilities for improved diagnostic techniques for detecting a disease that affects one in eight women in Europe at some point in their lives.
Published: 2 May 2018
EU-funded researchers are using the latest vaccine technologies and antigen discovery tools to develop a multi-stage, multi-antigen vaccine against Plasmodium falciparum, the parasite responsible for the deadliest form of malaria.
Published: 25 April 2018
Hundreds of millions of people each year are infected with Plasmodium vivax, the most widespread form of malaria worldwide. An EU-funded project is tackling the mosquito-borne parasite, leading cutting-edge research efforts to accelerate the development of effective vaccines.
Published: 25 April 2018
EU-funded researchers are developing a personalised dosing solution for chemotherapy targeting leukaemia using advanced microfluidic chips to meet the precise medical requirements of individual patients.
Published: 12 February 2018